Mannitol & MANNITOL 2080 Excipient Use in Nasal Dosage Forms

Mannitol

FDA Inactive Ingredient Details, DESCRIPTION

Suppliers

39 Listed Products, 1 Ingredion Pharma Solutions, 1 Pfanstiehl, 11 Roquette, 12 SPI Pharma, 1 Shijiazhuang Huaxu Pharmaceutical, 2 Microlex e.U, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Gangwal Healthcare, 1 DKSH, 2 Gangwal Chemicals, 1 BASF, 2 Kerry, 1 Rochem International Inc, 1 Sigachi Industries

REGULATORY FILINGS

14 Suppliers, 13 USDMF, 3 CEP/COS, 3 NDC API

SOLUTIONS BY APPLICATIONS

25 Fillers, Diluents & Binders, 10 Chewable & Orodispersible Aids, 10 Direct Compression, 9 Taste Masking, 4 Co-Processed Excipients, 4 Parenteral, 3 Disintegrants & Superdisintegrants, 3 Granulation, 1 API Stability Enhancers, 1 Thickeners and Stabilizers

ANALYTICAL SOLUTION(s)

1 Other Ref. Standards

1 Other Ref. Standards

FINISHED FORMULATIONS

497 ORAL, 277 TABLET, 130 INJECTABLE, 86 INJECTION, 68 TABLET, ORALLY DISINTEGRATING, 63 INTRAVENOUS, 42 CAPSULE, 33 OPHTHALMIC, 32 POWDER, 28 SOLUTION/DROPS, 28 TABLET, EXTENDED RELEASE, 26 TABLET, CHEWABLE, 23 TABLET, DELAYED RELEASE, 22 SUBLINGUAL, 16 FOR SUSPENSION, 12 SUBCUTANEOUS, 11 CAPSULE, DELAYED REL PELLETS, 10 SOLUTION, 8 BUCCAL, 8 GUM, CHEWING, 8 INTRAVENOUS, SUBCUTANEOUS, 7 FOR SOLUTION, 6 GRANULE, 6 TABLET, FOR SUSPENSION, 5 CAPSULE, EXTENDED RELEASE, 5 INTRAMUSCULAR, 5 TROCHE/LOZENGE, 3 VIAL, 2 BUCCAL, SUBLINGUAL, 2 ORAL-21, 2 ORAL-28, 2 SUSPENSION/DROPS, 2 TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE, 1 CAPSULE, DELAYED RELEASE, 1 FOR SUSPENSION, DELAYED RELEASE, 1 FOR SUSPENSION, EXTENDED RELEASE, 1 GEL, 1 INJECTABLE, LIPOSOMAL, 1 INJECTABLE, TABLET, 1 INTRAMUSCULAR, ORAL, 1 INTRAVITREAL, 1 IV (INFUSION), 1 NASAL, 1 SINGLE-USE, 1 SOLUTION, GEL FORMING/DROPS, 1 SPRAY, METERED, 1 SUSPENSION, 1 SUSPENSION, EXTENDED RELEASE, 1 TABLET, EXTENDED RELEASE, CHEWABLE, 1 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE

MARKET PLACE

2 APIs, 1 DOSSIERS // FDF, 28 EXCIPIENTS

MEDIA

1 Article #PharmaFlow, 3 News

Looking for Nasal Finished Formulations containing MANNITOL 2080? Find Mannitol based pharmaceutical excipients on PharmaCompass.

Mannitol

FDA Inactive Ingredient Details

DESCRIPTION

Suppliers

39 Listed Products

1 Ingredion Pharma Solutions

1 Pfanstiehl

11 Roquette

12 SPI Pharma

1 Shijiazhuang Huaxu Pharmaceutical

2 Microlex e.U

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Gangwal Healthcare

1 DKSH

2 Gangwal Chemicals

1 BASF

2 Kerry

1 Rochem International Inc

1 Sigachi Industries

REGULATORY FILINGS

14 Suppliers

13 USDMF

3 CEP/COS

3 NDC API

SOLUTIONS BY APPLICATIONS

25 Fillers, Diluents & Binders

10 Chewable & Orodispersible Aids

10 Direct Compression

9 Taste Masking

4 Co-Processed Excipients

4 Parenteral

3 Disintegrants & Superdisintegrants

3 Granulation

1 API Stability Enhancers

1 Thickeners and Stabilizers

ANALYTICAL SOLUTION(s)

1 Other Ref. Standards

FINISHED FORMULATIONS

497 ORAL

277 TABLET

130 INJECTABLE

86 INJECTION

68 TABLET, ORALLY DISINTEGRATING

63 INTRAVENOUS

42 CAPSULE

33 OPHTHALMIC

32 POWDER

28 SOLUTION/DROPS

28 TABLET, EXTENDED RELEASE

26 TABLET, CHEWABLE

23 TABLET, DELAYED RELEASE

22 SUBLINGUAL

16 FOR SUSPENSION

12 SUBCUTANEOUS

11 CAPSULE, DELAYED REL PELLETS

10 SOLUTION

8 BUCCAL

8 GUM, CHEWING

8 INTRAVENOUS, SUBCUTANEOUS

7 FOR SOLUTION

6 GRANULE

6 TABLET, FOR SUSPENSION

5 CAPSULE, EXTENDED RELEASE

5 INTRAMUSCULAR

5 TROCHE/LOZENGE

3 VIAL

2 BUCCAL, SUBLINGUAL

2 ORAL-21

2 ORAL-28

2 SUSPENSION/DROPS

2 TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE

1 CAPSULE, DELAYED RELEASE

1 FOR SUSPENSION, DELAYED RELEASE

1 FOR SUSPENSION, EXTENDED RELEASE

1 GEL

1 INJECTABLE, LIPOSOMAL

1 INJECTABLE, TABLET

1 INTRAMUSCULAR, ORAL

1 INTRAVITREAL